CS logo
small CS logo
The Mark H Zangmeister Center

Columbus, Ohio, United States
Cancer treatment center in Columbus, Ohio
3100 Plaza Properties Blvd, Columbus, OH 43219

About The Mark H Zangmeister Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
102
SWOG Cancer Research Network
40
Alliance for Clinical Trials in Oncology
29
ECOG-ACRIN Cancer Research Group
13
NRG Oncology
10
Genentech, Inc.
8
Hoffmann-La Roche
8
GOG Foundation
7
Gynecologic Oncology Group
7
Wake Forest University Health Sciences
5
Celgene
4
Total Rows: 44

Clinical Trials at The Mark H Zangmeister Center


During the past decade, The Mark H Zangmeister Center conducted 156 clinical trials. In the 10-year time frame, 156 clinical trials started and 108 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 51 clinical trials started and 61 clinical trials were completed. i.e. 119.6% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2222161618182020292924241414131311887714141717161622221717Started TrialsCompleted Trails20152016201720182019202020212022010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "The Mark H Zangmeister Center" #1 sponsor was "National Cancer Institute (NCI)" with 102 trials, followed by "SWOG Cancer Research Network" with 40 trials sponsored, "Alliance for Clinical Trials in Oncology" with 29 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "NRG Oncology" with 13 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 44 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Mark H Zangmeister Center" #1 collaborator was "National Cancer Institute (NCI)" with 116 trials as a collaborator, "NRG Oncology" with 36 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 50 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 102National CancerInstitute (NCI): 102SWOG Cancer ResearchNetwork: 40SWOG Cancer ResearchNetwork: 40Alliance for ClinicalTrials in Oncology: 29Alliance for ClinicalTrials in Oncology: 29ECOG-ACRIN CancerResearch Group: 13ECOG-ACRIN CancerResearch Group: 13NRG Oncology: 10NRG Oncology: 10Genentech, Inc.: 8Genentech, Inc.: 8Hoffmann-La Roche: 8Hoffmann-La Roche: 8GOG Foundation: 7GOG Foundation: 7Gynecologic Oncology Group: 7Gynecologic Oncology Group: 7Wake Forest UniversityHealth Sciences: 5Wake Forest UniversityHealth Sciences: 5

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 116National CancerInstitute (NCI): 116NRG Oncology: 36NRG Oncology: 36Canadian Cancer TrialsGroup: 10Canadian Cancer TrialsGroup: 10Genentech, Inc.: 3Genentech, Inc.: 3MillenniumPharmaceuticals, Inc.: 3MillenniumPharmaceuticals, Inc.: 3SWOG Cancer ResearchNetwork: 3SWOG Cancer ResearchNetwork: 3AstraZeneca: 2AstraZeneca: 2Bayer: 2Bayer: 2Biologics, Inc.: 2Biologics, Inc.: 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2

Clinical Trials Conditions at The Mark H Zangmeister Center


According to Clinical.Site data, the most researched conditions in "The Mark H Zangmeister Center" are "Recurrent Ovarian Carcinoma" (13 trials), "Breast Cancer" (11 trials), "Recurrent Fallopian Tube Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials) and "Stage IV Lung Cancer AJCC v8" (10 trials). Many other conditions were trialed in "The Mark H Zangmeister Center" in a lesser frequency.

Clinical Trials Intervention Types at The Mark H Zangmeister Center


Most popular intervention types in "The Mark H Zangmeister Center" are "Drug" (220 trials), "Other" (146 trials), "Biological" (85 trials), "Procedure" (56 trials) and "Radiation" (31 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (69 trials), "Quality-of-Life Assessment" (67 trials), "Paclitaxel" (42 trials), "Carboplatin" (41 trials) and "Questionnaire Administration" (40 trials). Other intervention names were less common.

Clinical Trials Genders at The Mark H Zangmeister Center


The vast majority of trials in "The Mark H Zangmeister Center" are 205 trials for "All" genders, 63 trials for "Female" genders and 8 trials for "Male" genders.

Clinical Trials Status at The Mark H Zangmeister Center


Currently, there are NaN active trials in "The Mark H Zangmeister Center". undefined are not yet recruiting, 70 are recruiting, 123 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 61 completed trials in The Mark H Zangmeister Center, 4 suspended trials, and 12 terminated clinical trials to date.
Out of the total trials that were conducted in The Mark H Zangmeister Center, 9 "Phase 1" clinical trials were conducted, 121 "Phase 2" clinical trials and 144 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 144Phase 3: 144Phase 2: 121Phase 2: 121Phase 1: 9Phase 1: 9Not Applicable: 7Not Applicable: 7Early Phase 1: 2Early Phase 1: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 123Active, not recruiting: 123Recruiting: 70Recruiting: 70Completed: 61Completed: 61Terminated: 12Terminated: 12Suspended: 4Suspended: 4Unknown status: 3Unknown status: 3Approved for marketing: 1Approved for marketing: 1Enrolling by invitation: 1Enrolling by invitation: 1No longer available: 1No longer available: 1